Haemodynamic responses to salbutamol and isometric exercise are altered in young adults with mild asthma

European Journal of Clinical Pharmacology

Volumn 61, Issue 1, 2005, Pages 9-14

  Waring, W Stephen ^a,b   Leigh, Rachel B ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; PLACEBO; SALBUTAMOL;

ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HAND GRIP; HEART INDEX; HEART RATE; HEMODYNAMICS; HUMAN; IMPEDANCE CARDIOGRAPHY; ISOMETRIC EXERCISE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STIMULUS; SYSTEMIC VASCULAR RESISTANCE;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ASTHMA; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXERCISE; FEMALE; HEART RATE; HUMANS; MALE;

EID: 17644405481     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-004-0880-7     Document Type: Article

References (27)

1. Lanes SF, Garcia-Rodriguez LA, Huerta C (2002) Respiratory medications and risk of asthma death. Thorax 57:683-686
2. Sears MR (2001) Short-acting beta-agonist research: a perspective 1997. Can Respir J 8:349-355
3. Beasley R, Pearce N, Crane J, Burgess C (1999) Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol 103:S18-S30
4. Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE (1990) Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 336:1396-1399
5. Hall JA, Petch MC, Brown MJ (1989) Intracoronary injections of salbutamol demonstrate the presence of functional beta-2 adrenoceptors in the human heart. Circ Res 65:546-553
6. Langer SZ (1980) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337-362
7. Mäki T, Kontula K, Härkönen M (1990) The beta-adrenergic system in man: physiological and pathophysiological response regulation of receptor density and function. Scand J Clin Lab Invest 50(Suppl 201):25-43
8. Stein CM, Nelson R, Deegan R, He H, Wood M, Wood AJJ (1995) Forearm beta adrenergic receptor-mediated vasodilatation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. J Clin Invest 96:579-585
9. Jartti TT, Kaila TJ, Yahvanainen KUO, Kuusela TA, Vanto TT, Valimaki IAT (1998) Altered cardiovascular autonomic regulation after salmeterol treatment in asthmatic children. Clin Physiol 18:345-353
10. Jartti TT, Kaila TT, Tahvanainen KUO, Kuusela TA, Vanto TT, Valimaki IAT (1997) Altered cardiovascular autonomic regulation after 2-week inhaled salbutamol treatment in asthmatic children. Eur J Pediatr 157:883-888
11. Grove A, Lipworth BJ (1995) Tolerance with the beta 2-adrenoceptor agonists: time for reappraisal. Br J Clin Pharmacol 39:109-118
12. Chapman KR, Smith DL, Rebuck AS, Leenen FH (1984) Hemodynamic effects of an inhaled beta-2 agonist. Clin Pharmacol Ther 35:762-767
13. Ewing DJ, Irving JB, Kerr F, Wildsmith JA, Clarke BF (1974) Cardiovascular responses to sustained handgrip in normal subjects and in patients with diabetes mellitus: a test of autonomic function. Clin Sci Mol Med 46:295-306
14. Waring WS, Chui M, Japp A, Nicol EF, Ford MJ (2004) Autonomic cardiovascular responses are impaired in women with irritable bowel syndrome. J Clin Gastroenterol 38:658-663
15. Silke B, McAuley D (1998) Accuracy and precision of blood pressure determination with the Finapres: an overview using resampling statistics. J Hum Hypertens 12:403-409
16. Thomas SH (1992) Impedance cardiography using the Sramek-Bernstein method: accuracy and variability at rest and during exercise. Br J Clin Pharmacol 34:467-476
17. Badr C, Elkins MR, Ellis ER (2002) The effect of body position on maximal expiratory pressure and flow. Aust J Physiother 48:95-102
18. Calhoun WJ, Sutton LB, Emmett A, Dorinsky PM (2003) Asthma variability in patients previously treated with beta2-agonists alone. J Allergy Clin Immunol 112:1088-1094
19. Fontana GA, Pantaleo T, Federico L, Bongianni F, Mannelli M, Bridge PD, Pistolesi M (2002) Handgrip-induced airway dilation in asthmatic patients with bronchoconstriction induced by MCh inhalation. J Appl Physiol 93:1723-1730
20. Jartti TT, Kuusela TA, Kaila TJ, Tahvanainen KUO, Valimaki AT (1998) The dose-response effects of terbutaline on the variability, approximate entropy and fractal dimension of heart rate and blood pressure. Br J Clin Pharmacol 45:277-285
21. Amadi A, Ponikowski P, Coats AJ (1995) Role of catecholamines and sympathetic activation as a risk factor for coronary artery disease. J Cardiovasc Risk 2:222-228
22. Hanratty CG, Silke B, Riddell JG (1999) Evaluation of the effect on heart rate variability of a beta 2-adrenoceptor agonist and antagonist using non-linear scatterplot and sequence methods. Br J Clin Pharmacol 47:157-166
23. Benovic JL (2002) Novel beta 2-adrenergic receptor signalling pathways. J Allergy Clin Immunol 110:S229-S235
24. Qing F, Rahman SU, Hayes MJ, Rhodes CG, Ind PW, Jones T, Hughes JM (1997) Effect of long-term beta 2-agonist dosing on human cardiac adrenoceptor expression in vivo: comparison with changes in lung and mononuclear leukocyte beta-receptors. J Nucl Cardiol 4:532-538
25. Larsson K (1985) Studies of sympatho-adrenal reactivity and adrenoceptor function in bronchial asthma. Eur J Respir Dis Suppl 141:1-52
26. Grove A, McFarlane LC, Lipworth BJ (1995) Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone. Thorax 50:134-138
27. Anderson PJ, Zhou X, Breen P, Gann L, Logsdon TW, Compadre CM, Hiller FC (1998) Pharmacokinetics of (R,S)-Albuterol after aerosol inhalation in healthy adult volunteers. J Pharm Sci 87:841-844